Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients
Public ClinicalTrials.gov record NCT00504452. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter, Mechanism Validation Study to Evaluate the Safety, Efficacy and Tolerability of KP-1461 as Monotherapy for 124 Days in Antiretroviral-experienced, HIV-1-infected Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of the study is to investigate the safety and efficacy of KP-1461 given every 12 hours for 124 days to HIV+ patients who have failed multiple antiretroviral regimens.
Study identification
- NCT ID
- NCT00504452
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 27 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2007 (Type not available)
- Primary completion
- Sep 2008 (Actual)
- Completion
- Jun 2009 (Actual)
- Last update posted
- Nov 7, 2011
2007 – 2009
United States locations
- U.S. sites
- 30
- U.S. states
- 19
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Health for Life Clinic | Little Rock | Arkansas | 72207 | — |
| Living Hope Clinical Foundation | Long Beach | California | 90813 | — |
| Light Source Medical/U. of Southern California | Los Angeles | California | 90036 | — |
| ACTU at CARES/UC Davis | Sacramento | California | 95817 | — |
| UCSD Antiviral Research Center | San Diego | California | 92103 | — |
| Quest Clinical Research | San Francisco | California | 94115 | — |
| Dupont Circle Physician's Group | Washington D.C. | District of Columbia | 20009 | — |
| Whitman-Walker Clinic | Washington D.C. | District of Columbia | 20009 | — |
| Comprehensive Care Center -- HIV Clinical Research | Fort Lauderdale | Florida | 33311 | — |
| Wohlfeiler, Piperato and Associates, LLC | North Miami Beach | Florida | 33169 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| Treasure Coast Infectious Disease Consultants | Vero Beach | Florida | 32960 | — |
| AIDS Research Consortium of Atlanta | Atlanta | Georgia | 30308 | — |
| Northstar Medical Center | Chicago | Illinois | 60657 | — |
| University of Kansas School of Medicine - PriVia, The Research Centers of Via Christi | Wichita | Kansas | 67214 | — |
| Institute of Human Virology, University of Maryland | Baltimore | Maryland | 21201 | — |
| Community Research Initiative of New England | Boston | Massachusetts | 02215 | — |
| Dybedal Center for Clinical Research, Kansas City University of Medicine and Biosciences | Kansas City | Missouri | 64106 | — |
| St. Michael's Medical Center | Newark | New Jersey | 07102 | — |
| Southwest CARE Center | Santa Fe | New Mexico | 87505 | — |
| Albany Medical College | Albany | New York | 12208 | — |
| AIDS Community Research Initiative of America | New York | New York | 10018 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| University of Cincinnati Medical Center | Cincinnati | Ohio | 45267 | — |
| Thomas Jefferson University, Division of Infectious Disease | Philadelphia | Pennsylvania | 19107 | — |
| Charlton Methodist Hospital | Dallas | Texas | 75204 | — |
| University of Texas Health Science Center | Houston | Texas | 77030 | — |
| CARE-ID | Annandale | Virginia | 22003 | — |
| University of Washington AIDS Clinical Trials Unit | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00504452, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2011 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00504452 live on ClinicalTrials.gov.